A detailed history of Cullen Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cullen Capital Management, LLC holds 4,498,231 shares of PFE stock, worth $126 Million. This represents 1.42% of its overall portfolio holdings.

Number of Shares
4,498,231
Previous 2,578,344 74.46%
Holding current value
$126 Million
Previous $74.2 Million 68.16%
% of portfolio
1.42%
Previous 1.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $49.7 Million - $57.1 Million
1,919,887 Added 74.46%
4,498,231 $125 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $36.6 Million - $47.6 Million
-1,402,358 Reduced 35.23%
2,578,344 $74.2 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $2.85 Million - $3.33 Million
-88,866 Reduced 2.18%
3,980,702 $132 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $107,926 - $124,868
2,988 Added 0.07%
4,069,568 $149 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $40.2 Million - $52.3 Million
1,019,440 Added 33.46%
4,066,580 $166 Million
Q4 2022

Feb 16, 2023

SELL
$41.75 - $54.5 $39.2 Million - $51.1 Million
-937,743 Reduced 23.53%
3,047,140 $156 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $13.6 Million - $16.6 Million
310,028 Added 8.44%
3,984,883 $174 Million
Q2 2022

Aug 11, 2022

SELL
$46.53 - $55.17 $1.65 Million - $1.96 Million
-35,514 Reduced 0.96%
3,674,855 $193 Million
Q1 2022

May 03, 2022

BUY
$45.75 - $56.69 $2.24 Million - $2.78 Million
48,971 Added 1.34%
3,710,369 $192 Million
Q4 2021

Feb 10, 2022

SELL
$41.32 - $61.25 $46.2 Million - $68.5 Million
-1,117,992 Reduced 23.39%
3,661,398 $216 Million
Q3 2021

Nov 05, 2021

SELL
$39.25 - $50.42 $6.73 Million - $8.65 Million
-171,544 Reduced 3.46%
4,779,390 $206 Million
Q2 2021

Aug 04, 2021

BUY
$35.91 - $40.68 $12.8 Million - $14.5 Million
356,787 Added 7.77%
4,950,934 $194 Million
Q1 2021

May 10, 2021

BUY
$33.49 - $37.77 $115 Million - $130 Million
3,446,388 Added 300.27%
4,594,147 $166 Million
Q4 2020

Jan 26, 2021

SELL
$33.47 - $42.56 $647,175 - $822,940
-19,336 Reduced 1.66%
1,147,759 $42.2 Million
Q3 2020

Nov 02, 2020

SELL
$31.75 - $37.25 $8.74 Million - $10.3 Million
-275,253 Reduced 19.08%
1,167,095 $42.8 Million
Q2 2020

Jul 31, 2020

SELL
$30.12 - $36.54 $8.46 Million - $10.3 Million
-280,970 Reduced 16.3%
1,442,348 $47.2 Million
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $69 Million - $98.6 Million
-2,553,243 Reduced 59.7%
1,723,318 $56.2 Million
Q1 2020

May 05, 2020

BUY
$27.03 - $38.62 $67.1 Million - $95.9 Million
2,482,308 Added 138.35%
4,276,561 $140 Million
Q4 2019

Jan 31, 2020

BUY
$32.92 - $37.36 $3.9 Million - $4.43 Million
118,595 Added 7.08%
1,794,253 $70.3 Million
Q3 2019

Nov 15, 2019

BUY
$32.49 - $42.13 $1.37 Million - $1.77 Million
42,045 Added 2.57%
1,675,658 $60.2 Million
Q2 2019

Jul 30, 2019

BUY
$36.98 - $41.52 $158,089 - $177,498
4,275 Added 0.26%
1,633,613 $70.8 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $220,500 - $242,256
5,880 Added 0.36%
1,629,338 $69.2 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $4.96 Million - $5.66 Million
-129,032 Reduced 7.36%
1,623,458 $70.9 Million
Q3 2018

Nov 15, 2018

BUY
$34.47 - $41.81 $231,466 - $280,754
6,715 Added 0.38%
1,752,490 $77.2 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $5.12 Million - $5.46 Million
-155,170 Reduced 8.16%
1,745,775 $63.3 Million
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $1.19 Million - $1.38 Million
37,290 Added 2.0%
1,900,945 $67.5 Million
Q4 2017

Feb 15, 2018

SELL
$33.26 - $35.29 $667,528 - $708,270
-20,070 Reduced 1.07%
1,863,655 $67.5 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $2.59 Million - $2.85 Million
83,441 Added 4.63%
1,883,725 $67.2 Million
Q2 2017

Aug 16, 2017

BUY
N/A
1,800,284
1,800,284 $60.5 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cullen Capital Management, LLC Portfolio

Follow Cullen Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cullen Capital Management, LLC with notifications on news.